DOT Drug Testing Locations Kirklin, IN
Our Local DOT Drug testing facilities in Kirklin, IN and the surrounding areas provide DOT Drug Testing, DOT Alcohol Testing, DOT Physicals, Consortium enrollment and other DOT services for Employers, Single operators and all DOT modes that are required to comply with 49 CFR Part 40 in Kirklin, IN including FMCSA, FTA, FAA, USCG, FRA and PHMSA . Testing centers are within minutes of your home or office and same-day service is available in most cases.
Scheduling a DOT test is Fast and Easy, call our scheduling department or schedule your test online 24/7
* You must register by phone or online to receive your donor pass/registration prior to proceeding to the testing center.
1805 E WABASH ST 9.1 miles
FRANKFORT, IN 46041
550 S HOKE AVE 9.2 miles
FRANKFORT, IN 46041
1300 S JACKSON ST 9.5 miles
FRANKFORT, IN 46041
1258 OAK ST STE B 9.6 miles
FRANKFORT, IN 46041
1400 DAN CONN DR 11.0 miles
LEBANON, IN 46052
517 W NOBLE ST 12.2 miles
LEBANON, IN 46052
400 N MOUNT ZION RD 12.7 miles
LEBANON, IN 46052
350 N MOUNT ZION RD STE 400 12.7 miles
LEBANON, IN 46052
300 FAIRGROUNDS RD 17.5 miles
TIPTON, IN 46072
1000 S MAIN ST 17.8 miles
TIPTON, IN 46072
13400 N MERIDIAN ST 18.4 miles
CARMEL, IN 46032
13636 N MERIDIAN ST 18.5 miles
CARMEL, IN 46032
11911 N MERIDIAN ST STE 150 19.3 miles
CARMEL, IN 46032
865 WESTFIELD RD Ste D 20.0 miles
NOBLESVILLE, IN 46062
493 WESTFIELD RD 20.4 miles
NOBLESVILLE, IN 46060
277 E CARMEL DR 20.4 miles
CARMEL, IN 46032
8150 WOODLAND DR 20.9 miles
INDIANAPOLIS, IN 46278
3803 SOUTHLAND AVE 21.1 miles
KOKOMO, IN 46902
186 E SOUTHWAY BLVD 21.3 miles
KOKOMO, IN 46902
2001 W 86TH ST 21.3 miles
INDIANAPOLIS, IN 46260
3500 S LAFOUNTAIN ST 21.4 miles
KOKOMO, IN 46902
8330 NAAB RD STE 104 21.5 miles
INDIANAPOLIS, IN 46260
7301 GEORGETOWN RD Ste 109 21.6 miles
INDIANAPOLIS, IN 46268
1136 SHADOW RIDGE RD 21.8 miles
INDIANAPOLIS, IN 46280
5604 W 74TH ST 21.8 miles
INDIANAPOLIS, IN 46278
3109 W SYCAMORE ST Ste B 22.5 miles
KOKOMO, IN 46901
860 E 86TH ST ste 4 22.6 miles
INDIANAPOLIS, IN 46240
925 S UNION ST 23.1 miles
KOKOMO, IN 46901
9669 E 146TH ST STE 175B 23.3 miles
NOBLESVILLE, IN 46060
9669 E 146TH ST STE 100 23.3 miles
NOBLESVILLE, IN 46060
6447 WARREN LN 23.5 miles
BROWNSBURG, IN 46112
11530 ALLISONVILLE RD STE 135 23.6 miles
FISHERS, IN 46038
14540 PRAIRIE LAKES BLVD N STE 104 23.6 miles
NOBLESVILLE, IN 46060
1010 S REED RD 23.7 miles
KOKOMO, IN 46901
12-5-29/1, Opp. Andhra Bank Whitehouse, Tarnaka 24.1 miles
Hyderabad, IN 0
H No 2-20/6/A, Kothaguda X Roads Near Harsha Toyota Showroom 24.1 miles
Kondapur, IN 0
SCO-15, Ground Floor, Sector-14 Gurgaon 24.1 miles
Haryana, IN 0
32 Sassoon Rd Pune 411 001 24.1 miles
Pune, IN 0
270,3rd,Cross,Domlur 2nd Stage, Indira Nagar Kamataka 24.1 miles
Bangalore, IN 0
8/2 Ravi Bldg, Next to ALKA TALKIES Maharastra 24.1 miles
Pune, IN 0
SCO 68-69, Sector 55-56 24.1 miles
Haryana, IN 0
SCO 1 & 2, Sector 14 Old Delhi Gurgaon Rd 24.1 miles
Gurgaon, IN 0
No 83/87, Ground Floor Soundaraya Paramount, 5th Cross 24.1 miles
Malleshwaram, IN 0
No.15, Jyoti Nivas College Rd 5th Block, Koramangala 24.1 miles
Bangalore, IN 0
7411 N KEYSTONE AVE STE B 24.5 miles
INDIANAPOLIS, IN 46240
(Don't see a DOT drug testing location near you, call us at (800) 221-4291)
Accredited Drug Testing can schedule your DOT drug test at any of our Kirklin, IN Drug testing locations, Call us Today!
"When you need a test, choose the best"
How to schedule a DOT drug test in Kirklin, IN
To schedule any type of DOT drug test or alcohol test in Kirklin, IN call our local scheduling department at (800) 221-4291. You may also schedule your DOT drug test online utilizing our express scheduling registration system by selecting your test and completing the Donor Information/Registration Section. You must register for the test prior to proceeding to the testing center.
The zip code you enter will be used to determine the closest DOT drug or DOT alcohol testing center that performs the type of test you have selected. A donor pass/registration form with the local testing center address, hours of operation and instructions will be sent to the e-mail address you provided. Take this form with you or have it available on your smartphone to provide to the testing center. No appointment is necessary in most cases. However, you must complete the donor information section and pay for the test at the time of registration.
Our laboratories are SAMHSA-certified and all test results are verified by our in-house licensed physicians who serve as Medical Review Officers (MRO).
In addition to providing DOT drug testing and DOT breath alcohol testing in Kirklin, IN , Accredited Drug Testing also has additional testing centers throughout the metropolitan area and surrounding cities.
On the road or on vacation, no worries, Accredited Drug Testing has over 20,000 testing centers in all cities Nationwide and we can schedule your test, ANYWHERE, ANYTIME!
DOT Changes to Part 40
On May 2, 2023, the Department of Transportation published its final rule in the Federal Register to include oral fluid testing in the DOT drug testing program. This final rule became effective June 1, 2023.
Please note that DOT oral fluid testing cannot be implemented as of yet until the Department of Health and Human Services (HHS) certifies at least two laboratories. One as a primary lab and a second lab to serve as split specimen testing.
Changes to DOT-regulated employees?
DOT-regulated safety-sensitive employees can now be subject to an oral fluid collection or urine drug testing collection for ANY DOT-regulated test and this choice is up to the employer. DOT has also authorized that Substance Abuse Professionals (SAP) evaluations may continue to be conducted remotely.
How do these changes affect DOT employers?
Employers must select what methodology they would like to use for their drug testing program (randoms' oral fluid, pre-employment urine, etc). Ensure you have a business relationship/agreement with any collections site for the services you wish to use for your drug testing program. As an employer, you must also have your Designated Employer representative available 24-7 in the event any problem collections or situations arise or to discuss any standing orders that may arise for problem collections.
What are the DOT drug testing requirements?.
In 1991, the Omnibus Transportation Employee Testing Act created the following DOT Agencies which established drug and alcohol testing regulations to ensure that aircraft, trains, trucks, and buses were operated in a safe and responsible manner. As an employer or individual operating in a "Safety Sensitive" position, it is important to understand how these regulations impact you.
49 CFR Part 40 (commonly known as Part 40) explains:
- How drug and alcohol testing is conducted
- Who is authorized to participate in the drug and alcohol testing program
- What employees must do before they may return to duty after a drug and/or alcohol violation
Each DOT Agency and the USCG have specific regulations that cover:
- The agency's prohibitions on drug and alcohol use
- Who is subject to comply with these regulations
- What type of testing is required
- When testing is required
- Consequences of non-compliance
FMCSA Drug and Alcohol Clearinghouse
The Federal Motor Carrier Safety Administration (FMCSA) amended its rule that would establish requirements for commercial driver's license employers and individuals with regard to the drug and alcohol clearing house which will take effect on January 6, 2020.
The FMCSA Clearinghouse is a secure online database that will allow employers, the FMCSA, State Driver Licensing Agencies, State Law Enforcement and individual CDL operators to access real-time important information about a CDL Driver's drug and alcohol program violations and the ultimate goal of this database is to enhance safety on our Nation's public roadways.
For specific requirements, click the appropriate agency listed below in which you or your company is regulated by. Ask about our DOT Complete Compliance Package!
- Federal Aviation Administration (FAA) (14 CFR Part 120)
- United States Coast Guard (USCG) (46 CFR Parts 4,5 and 16)
- Federal Motor Carrier Safety Administration (FMCSA) (49 CFR Part 382)
- Pipeline and Hazardous Materials Safety Administration (PHMSA) (49 CFR Part 199)
- Federal Transit Administration (FTA) (49 CFR Part 655)
- Federal Railroad Administration (FRA) (49 CFR Part 219)
The Opioid Overdose Crisis
Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids,including prescription pain relievers, heroin, and synthetic opioids such as fentanyl, is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.
- Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.
- Between 8 and 12 percent develop an opioid use disorder.
- An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
- About 80 percent of people who use heroin first misused prescription opioids.
- Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.
- The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.
- Opioid overdoses in large cities increased by 54 percent in 16 states.
In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder (not mutually exclusive)
DOT Compliance Checklist in Kirklin, IN
DOT 49 CFR Part 40 Requirements for Safety Sensitive Employees.
(FMCSA-FAA-USCG-FRA-PHMSA-FTA)
- Pre-Employment Tests
- Correct Federal Custody & Control Form (CCF)
- Substance Abuse Professional Process
- Regulations on File
- Random Pool Testing
- *Supervisor Training
- *Written Policy
- Post-Accident Testing Situations
- Previous Employers Checks
- Employee Education
- Record Keeping
- Removal of covered Employee
- Designated Employer Representative
* In addition, any company which employs 2 or more covered employees must have a written drug and alcohol policy and all supervisors must complete the DOT Supervisor Reasonable Suspicion Training. (Click here to learn more about our online training programs)
If a DOT covered employee or company does not have a copy of the original pre-employment drug test with a negative result, then a new DOT pre-employment drug test must be conducted, and the result maintained on file.
The department of transportation (DOT) requires that all DOT regulated "safety sensitive" employees have on file a negative DOT pre-employment drug test result and be a member of a DOT approved random selection consortium. In addition, if a DOT regulated company has more than one "safety sensitive" employee, the employer must also have a written DOT drug and alcohol policy and an on-site supervisor must have completed supervisor training for reasonable suspicion of illegal drug use or impairment.
To be compliant with DOT regulations, a company's DOT drug and alcohol testing program must have the following components. Failing to comply can result in significant fines and penalties.
What is a DOT Drug Test in Kirklin, IN ?
On January 1, 2018 the Department of Transportation (DOT) issued a new rule which altered the DOT 5 panel urine test. Employers and individuals should be aware that the current DOT drug test is still a urine drug test, collected by qualified collectors, analyzed at a SAMHSA certified laboratory and reviewed by a licensed Medical Review Officer. Below you will find a list of the drugs that are screened for in the DOT 5 panel urine drug test:
- Marijuana (THC)
- Cocaine
- Amphetamines
- Opioids**
- Phencyclidine (PCP)
- Pre-employment
- Random
- Reasonable suspicion
- Return to Duty
- Post-Accident
- Follow Up
** Special note: Opioids' was previously called Opiates' and all DOT drug tests will continue to include confirmation testing for Codeine, Morphine, and 6-AM (heroin) when necessary.
In the January rule change, the Department of Transportation (DOT) also added initial screening and confirmation testing for the semi-synthetic opioids Hydrocodone, Hydromorphone, Oxycodone, and Oxymorphone to this Opioids group
When is a DOT drug test required in Kirklin, IN ?
All safety sensitive employees regardless of DOT agency are required for the following drug testing and/or alcohol testing based on each situation:
What is DOT pre employment testing in Kirklin, IN ?
As a new hire or a current employee transferring from a non-safety sensitive function into a safety sensitive function (even with the same employer), you are required to submit to a DOT pre employment drug test.
Some employers may, but are not required to, conduct pre employment alcohol testing. Only after your employer receives a negative pre employment DOT drug test result (and negative alcohol test result - if administered) may you begin performing in a safety-sensitive capacity.
What is random DOT Drug Testing in Kirklin, IN ?
All safety sensitive employees are subject to unannounced random drug & alcohol testing. Alcohol testing is administered just prior to, during or just after performing safety-sensitive functions. Depending on the industry specific regulations, you may only be subject to random drug testing.
Listed below are the current (2019) DOT random testing rates for each DOT agency.
| The following chart outlines the annual minimum drug and alcohol random testing rates established within DOT Agencies and the USCG for 2019. | ||
| DOT Agency | 2019 Random Drug Testing Rate | 2019 Random Alcohol Testing Rate |
|---|---|---|
| Federal Motor Carrier Safety Administration [FMCSA] | 25% | 10% |
| Federal Aviation Administration [FAA] | 25% | 10% |
| Federal Railroad Administration [FRA] | 25% - Covered Service 50% - Maintenance of Way * | 10% - Covered Service 25% - Maintenance of Way * |
| Federal Transit Administration [FTA] | 50% | 10% |
| United States Coast Guard [USCG] (with the Dept. of Homeland Security) | 50% | N/A |
| The following chart outlines the annual minimum drug and alcohol random testing rates established within DOT Agencies and the USCG for 2019. |
| DOT Agency 2019 Random Drug Testing Rate 2019 Random Alcohol Testing Rate |
|---|
| Federal Motor Carrier Safety Administration [FMCSA] 25% 10% |
| Federal Aviation Administration [FAA] 25% 10% |
| Federal Railroad Administration [FRA] 25% - Covered Service / 50% - Maintenance of Way * 10% - Covered Service / 25% - Maintenance of Way * |
| Federal Transit Administration [FTA] 50% 10% |
| United States Coast Guard [USCG] (with the Dept. of Homeland Security) 50% N/A |
What is reasonable suspicion DOT drug testing in Kirklin, IN ?
Safety sensitive individuals and employees are required to submit to any test (whether it is a drug test, alcohol test or both) that a supervisor requests based on reasonable suspicion. Reasonable suspicion means that one or more trained supervisors reasonably believes or suspects that you are under the influence of drugs or alcohol. Supervisors cannot require testing based on a hunch or guess alone; their suspicion must be based on observations concerning your appearance, behavior, speech and smell that are usually associated with drug or alcohol use
What is return to duty DOT Drug Testing in Kirklin, IN ?
If you have violated the prohibited drug & alcohol testing rules, you are required to take a return to duty drug and/or alcohol test before being allowed to return to a safety-sensitive function for any DOT regulated employer. You may also be subject to unannounced follow-up testing for at least 6 times in the first 12 months following your return to active safety-sensitive service.
Return-to-duty tests must be conducted under direct observation.
What is DOT post accident drug testing Kirklin, IN ?
If you are involved in an event (accident, crash, etc.) meeting certain criteria of the DOT agency, a post-accident drug test will be required. In most cases you will then have to take a drug and alcohol test if you are involved in a qualifying crash. Each DOT agency may have specific rules with regards to what is a post-accident test, for example, the FRA requires a blood specimen for drug testing and an alcohol test.
If you are involved in a qualifying accident, you are required to remain available for this testing and are not permitted to refuse testing.
Remember: Safety-sensitive employees are obligated by law to submit to and cooperate in drug & alcohol testing mandated by DOT regulations.
What is DOT follow up drug testing Kirklin, IN ?
DOT follow up testing occurs when an individual has violated the drug and alcohol testing rules. The amount of follow-up testing you receive is determined by a Substance Abuse Professional (SAP) and may continue for up to 5 years. This means the SAP will determine how many times you will be tested (at least 6 times in the first year), for how long, and for what substance (i.e. drugs, alcohol, or both). Your employer is responsible for ensuring that follow-up testing is conducted and completed. Follow up testing is in addition to all other DOT required testing and all follow-up tests will be observed. For more information on the SAP process or to locate a Substance Abuse Professional in Kirklin, IN simply call us at (800)221-4291
When you need a test, choose the best!
DOT Drug Testing Services Kirklin, IN
(800)221-4291
For more information regarding the effects of drug abuse - Click Here
For more information on a drug free work place - Click Here
Handy Resources
Comprehensive Online Resources for Drug Testing
- National Institute on Drug Abuse (NIDA)
Provides comprehensive information on drug testing and its role in substance use disorder treatment.
- FDA: Drug Testing
Explains the FDA's role and regulations concerning drug testing for consumers.
- PDR.net
Provides detailed drug information and safety updates through a mobile-friendly platform.
- BeSafeRx - FDA
Resource by the FDA to help consumers identify and choose safe online pharmacies.
- SAMHSA: Drug Testing Resources for the Workplace
Resources and guidelines for drug testing in the workplace.
- Drugs.com
Provides drug information, side effects, and interactions for consumers and professionals.
- Drug Abuse Screening Test (DAST)
Online version of the DAST to help individuals assess whether they have a drug problem.
- Merck Manuals
Consumer-friendly medical resource providing comprehensive information on a wide array of health topics, including drug testing.
- SAMHSA Store
Provides access to resources and publications on substance use prevention and treatment.
- National Association of Boards of Pharmacy (NABP)
Information on state boards of pharmacy and regulations, including those related to drug testing.
- CDC: Workplace Health Promotion
CDC's resources on substance use and drug testing in the workplace.
- Mayo Clinic: Drug Testing
General information about the procedures and types of drug tests.
- MedlinePlus: Drug Testing
Offers information about various drug tests and their uses in medical diagnosis and treatment.
- University of Rochester Medical Center Health Encyclopedia
Provides a detailed entry on drug testing, including how tests are conducted and what they detect.
- World Health Organization (WHO)
International guidelines and information on public health, including substance abuse and drug testing.
- Healthline: Drug Testing
Consumer health site offering information on how drug tests work and what they look for.
- WebMD: Drug Testing
Provides a patient-oriented overview of drug testing and its purposes.
- National Center for Biotechnology Information (NCBI)
Provides a vast database of scientific studies, including research on drug testing and its effectiveness.
AI Overview
Overview of Drug Testing Collection Locations
Drug testing collection locations are designated sites where individuals provide samples for drug testing. These facilities are crucial in supporting compliance with workplace, legal, and health standards. They serve a variety of sectors, including employment, law enforcement, sports, and healthcare. This overview explores the features, types of locations, and the role they play in drug testing processes.
Types of Drug Testing Collection Locations
- Occupational Health Clinics: Many clinics offer drug testing services as part of broader occupational health support.
- Hospital-Based Laboratories: Some hospitals have specific departments dedicated to drug testing, particularly for medical or legal purposes.
- Third-Party Laboratory Facilities: Independent labs that specialize in toxicology may also conduct drug testing, often used by employers for employment screening.
- Mobile Collection Units: These are portable facilities that can travel to workplaces or institutions, providing convenient access to drug testing services.
Role of Collection Locations in Drug Testing
Collection locations are integral to the drug testing process, ensuring that samples are collected in a controlled and secure environment. The main responsibilities include:
- Ensuring Sample Integrity: Implementing procedures that prevent tampering or contamination of samples.
- Maintaining Privacy: Providing a private space for individuals to give samples while respecting their confidentiality.
- Compliance with Standards: Adhering to regulatory and legal standards for drug testing, which may vary by jurisdiction and industry.
Choosing the Right Collection Location
When selecting a drug testing collection location, consider the following factors:
- Accreditation: Ensure the facility is accredited by relevant health and safety organizations.
- Proximity: Choose a location that is conveniently accessible, reducing the time and disruption associated with the testing process.
- Services Offered: Some locations may offer rapid results or additional screening services, which can be beneficial depending on the testing needs.
Drug testing collection locations are essential for conducting effective and reliable drug screenings. They support the enforcement of drug-free policies in various settings by providing professional and standardized testing services. For consumers and organizations alike, understanding the role and choosing the appropriate collection location is key to achieving accurate drug testing outcomes.
Were you looking, instead, for:
Local Area Info: James Kirklin
James K. Kirklin (born 1947 in Rochester, Minnesota) is an American cardiac surgeon who has made significant scientific and surgical contributions in the fields of heart transplantation and mechanical circulatory support devices to assist the pumping action of the heart. He is Professor of Surgery, former Director of the Division of Cardiothoracic Surgery (2006-2016), Director of the James and John Kirklin Institute for Research in Surgical Outcomes (KIRSO) (2016–present), former Co-Director of University of Alabama (UAB) Comprehensive Cardiovascular Center and holds the James Kirklin Chair of Cardiovascular Surgery at the UAB.
Kirklin is the son of the late heart surgery pioneer John W. Kirklin. He graduated from Ohio State University in 1969, where he was an All-American diver. He received his MD from Harvard Medical School in 1973 as a member of the Alpha Omega Alpha academic honor society. Subsequently, he completed general and cardiothoracic surgery residencies at Massachusetts General Hospital in 1978 where he was Chief Resident, and pursued additional training at Boston Children's Hospital in 1979 and UAB School of Medicine, where he completed his training in 1981. He was appointed Assistant Professor of Surgery at UAB in 1981, Director of Cardiac Transplantation in 1986, Professor of Surgery in 1987, and in 2006 was named Director of the Division of Cardiothoracic Surgery. Kirklin's surgical expertise included surgery for congenital heart disease, heart transplantation, and mechanical circulatory support pumps. In 2012, Kirklin and his colleagues developed the first Children's Hospital pediatric cardiac surgical unit in the state of Alabama. In 2017, at the age of 70, he retired from clinical surgery to direct the Kirklin Institute for Research in surgical outcomes.
Kirklin and his colleagues at UAB pioneered the development of multi-institutional collaborative outcomes research in pediatric and adult heart transplantation and mechanical circulatory support. In 2007, he was the first surgeon to bridge an infant with failing single ventricular heart to successful heart transplantation, with a longer term pediatric heart assist device called the Berlin Heart ventricular assist device. In 2011, he was the first surgeon in North America to implant the HVAD continuous flow ventricular assist device in a child. This nine-year-old girl was supported for 60 days and she then underwent successful cardiac transplantation. In 2014, Kirklin was the first surgeon in North America to implant the Eva Heart continuous flow ventricular assist device. In 2015, Kirklin led the surgical team that implanted the Berlin Heart on the youngest baby (17 days old) to receive extended (greater than 1 month) mechanical circulatory support (136 days) before undergoing successful heart transplantation.